Skip to main content

Utility Nav

  • About Us
    • Blog
    • History
    • Administrative Leaders
    • Clinical Leaders
    • Research Leaders
    • External Advisory Committee
    • Administrative Offices
    • Care Connect
    • News & Publications
    • Events
    • International Partners
    • Careers
  • Locations
  • Contact Us
  • Giving
  • Patient Portal
  • Katz School of Medicine

Utility Nav 2

  • Find a Doctor
  • Request Appointment
  • 888-369-2427

Main navigation

  • Clinical Care
    • Why Choose Fox Chase
    • Cancer Types & Conditions
    • Prevention & Screening
    • Support
    • Clinical Trials
    • Departments
    • Patient Stories
  • Research & Training
    • Overview
    • Scientists
    • Faculty Publications
    • Research Programs
    • Research Institutes
    • Clinical Trials & Research
    • Facilities
    • Training & Education
  • Patients & Visitors
    • Appointments
    • Insurance & Financial Information
    • Visitor Information
    • Locations
    • Partners
    • International Patients
    • Where to Stay
  • Healthcare Professionals
    • Refer a Patient
    • Physician Resources
    • Key Account Managers
    • Care Connect for Physicians
    • Continuing Education
    • Careers
    • eNewsletters
  • Community
    • Volunteer
    • Community Outreach
    • Community Health
    • Patient and Family Advisory Council
    • Walk & Run Events
888-369-2427

Utility Nav 2

  • Find a Doctor
  • Request Appointment
  • 888-369-2427
  • main menu
    Back One Level
  • Summer 2019
  • Delivering an Effective Radiation Dose to Liver Tumors
  • Is Surgery Necessary for Melanoma with Sentinel Node Metastasis?
  • New Systemic Therapies for Advanced HCC
  • New Tool Rapidly Matches Patients to Clinical Trials Based on Patient-Specific Eligibility
  • The Latest Cellular Immunotherapies Only Available at Certified Cancer Centers

Breadcrumb

  1. Home
  2. Healthcare Professionals
  3. eNewsletters
  4. ONC eNewsletter
  5. Oncology News Connection: Summer 2019
  • eNewsletters
    • ONC eNewsletter
      • Winter 2021
        • Fox Chase Clinical Trial Program Adapts During the COVID-19 Pandemic
        • Pulsed Low-Dose-Rate Radiation Offers New Treatment Option for Variety of Solid Tumors
        • Fox Chase Offering Prostate Micro-Ultrasound Technology
        • CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma
        • International Collaboration Finds Ripretinib Significantly Improves Survival for Patients With Advanced Gastrointestinal Stromal Tumors
      • Winter 2020
        • Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
        • Fox Chase Researchers Actively Recruiting For Breast Cancer Immunotherapy Trials
        • PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer
        • Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment
        • Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer
        • Identification and Management of Immunotherapy Toxicities
      • Summer 2019
        • Delivering an Effective Radiation Dose to Liver Tumors
        • Is Surgery Necessary for Melanoma with Sentinel Node Metastasis?
        • New Systemic Therapies for Advanced HCC
        • New Tool Rapidly Matches Patients to Clinical Trials Based on Patient-Specific Eligibility
        • The Latest Cellular Immunotherapies Only Available at Certified Cancer Centers
      • Winter 2019
        • De-escalating Treatment for Bladder and Prostate Cancers
        • Many Women With Early-Stage Breast Cancer Can Skip Chemotherapy
        • Men With Metastatic Prostate Cancer Need Genetic Testing
        • Retroperitoneal Sarcoma’s Radiation Therapy Options Are Expanding
        • The Fastest Growing Oncology Population
    • Updates in Urologic Oncology
      • Fall 2020
        • Fox Chase Now Offering Prostate Micro-Ultrasound Technology
        • Surgeon, Mother, Pioneer: Surgical Oncologist Rosalia Viterbo, MD, Is Committed to It All
        • Urologic Oncology APC and MD Author Book Chapter on Kidney Cancer
        • Fox Chase Cancer Center Welcomes Andres F. Correa, MD
      • Winter 2020
        • Fox Chase Offers InPACT Trial for Penile Cancers
        • International Collaborations Help Optimize Partial Nephrectomy Techniques
        • Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery
        • Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology Practice
        • Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients
        • Patient-Reported Quality of Life Research May Guide Treatment Decisions for Lower-Risk Prostate Cancer
      • Summer 2019
        • Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
        • Finding More Ways for Bladder Cancer Patients to Keep Their Bladders Through Clinical Trials
        • Investigating the Roles of Immune Responses, Bacteria in Curing Bladder Cancer with Chemotherapy
        • SpaceOAR Hydrogel Reduces Side Effects of Prostate Cancer Radiation Therapy
        • Spotlight on Lisa Hicks, RN, BSN, OCN
        • Treating Advanced Renal Cell Carcinoma with a New Drug Combination
      • Fall 2018
        • Cryosurgery’s Clinical Benefit: Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer
        • How to Find the 30 Percent: Tackling Diagnostic Challenges Following Muscle Invasive Bladder Cancer Treatment
        • Meet Tina Larason: Clinic Coordinator of Fox Chase’s Urologic Oncology Practice
        • Robert Uzzo Receives SUO Medal for Contributions to Urologic Oncology
        • Spring 2018 AUA & SUO Presentations
        • Surgical Consultations Now Available in Fox Chase’s East Norriton Offices
    • Clinical Connections
      • CivaSheet
ONC: Oncology News Connection from Fox Chase Cancer Center

A Fox Chase Cancer Center publication for physicians

Oncology News Connection: Summer 2019

Oncology News Connection: Summer 2019

The Latest Cellular Immunotherapies Only Available at Certified Cancer Centers

Is Surgery Necessary for Melanoma with Sentinel Node Metastasis?

Delivering an Effective Radiation Dose to Liver Tumors

New Systemic Therapies for Advanced HCC

New Tool Rapidly Matches Patients to Clinical Trials Based on Patient-Specific Eligibility

Share
  • Share with Facebook facebook-icon
  • Share with twitter twitter-icon
  • Share with email email-icon
  • Print this print-icon
Resize Text

The information presented in Oncology News Connection (ONC) eNewsletter is provided for physicians and other healthcare providers only and should not be shared with any current or future patients. If you are not a healthcare provider, we welcome you to sign up for Thrive eNewsletter to receive the latest information and blog highlights from Fox Chase Cancer Center.

888-369-2427

Fox Chase Cancer Center
Main Campus
333 Cottman Avenue
Philadelphia, PA 19111-2497

Connect with Fox Chase

  • Facebook Icon
  • Twitter Icon
  • Instagram Icon
  • Linkedin Icon
  • Flickr Icon
  • Youtube Icon
  • Appointments
  • Careers
  • Contact Us
  • Pay a Bill
  • Financial Assistance/Charity Care
  • Giving
  • Patient Portal
  • Temple Health
  • Lewis Katz School of Medicine
  • Temple University
  • A National Cancer Center Comprehensive Center
    National Comprehensive Cancer Network (NCCN)

©2022 Temple University Health System, Inc., Philadelphia, Pennsylvania. All rights reserved.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Lewis Katz School of Medicine at Temple University. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

  • Terms of Use
  • Patient Rights
  • Privacy & Non-Discrimination Notices
  • TUHS Vendor Policies & Procedures